Enzalutamide for metastatic hormone‑relapsed prostate cancer previously treated with a docetaxel‑containing regimen

Supporting evidence

• Review decision

• Review decision – December 2017

• Review decision paper (PDF 163 KB)

  Published:

  04 January 2018

• Review Decision – April 2016